Increased expression of cystic fibrosis transmembrane conductance regulator in rat liver after common bile duct ligation

Journal of Cellular Physiology

Volumn 203, Issue 3, 2005, Pages 599-603

  Shen, Hong ^a   Fan, Yijun ^b   Xi, Yang ^b   Burczynski, Frank J ^a   Li, Ping ^c   Gong, Yuewen ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; COMMON BILE DUCT; CONTROLLED STUDY; CYSTIC FIBROSIS; IMMUNOHISTOCHEMISTRY; LIVER DISEASE; MALE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE SECTION;

ANIMALS; BILIARY TRACT; BILIRUBIN; BODY WEIGHT; COMMON BILE DUCT; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIGATION; LIVER DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UP-REGULATION;

EID: 18244362560     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20259     Document Type: Article

References (33)

1. Ackerman Z, Karmeli F, Amir G, Rachmilewitz D. 1996. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats. J Hepatol 24(4):478-486.
2. Berger HA, Anderson MP, Gregory RJ, Thompson S, Howard PW, Maurer RA, Mulligan R, Smith AE, Welsh MJ. 1991. Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. J Clin Invest 88(4):1422-1431.
3. - channel by specific protein kinases and protein phosphatases. J Biol Chem 268(3):2037-2047.
4. Bradbury NA. 1999. Intracellular CFTR: Localization and function. Physiol Rev 79(1 Suppl):S175-191.
5. Braunstein GM, Roman RM, Clancy JP, Kudlow BA, Taylor AL, Shylonsky VG, Jovov B, Peter K, Jilling T, Ismailov II, Benos DJ, Schwiebert LM, Fitz JG, Schwiebert EM. 2001. Cystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation. J Biol Chem 276(9):6621-6630.
6. Cohn JA, Strong TV, Picciotto MR, Nairn AC, Collins FS, Fitz JG. 1993. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 105(6):1857-1864.
7. Colombo C, Battezzati PM, Strazzabosco M, Podda M. 1998. Liver and biliary problems in cystic fibrosis. Semin Liver Dis 18(3):227-235.
8. Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT. 1997. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child 77(6):493-496.
9. Elias JM, Gown AM, Nakamura RM, Wilbur DC, Herman GE, Jaffe ES, Battifora H, Brigati DJ. 1989. Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission. Am J Clin Pathol 92(6):836-843.
10. Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, Wilson JM. 1994. Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 93(2):737-749.
11. Fitz JG, Basavappa S, McGill J, Melhus O, Cohn JA. 1993. Regulation of membrane chloride currents in rat bile duct epithelial cells. J Clin Invest 91(1):319-328.
12. Fouassier L, Duan CY, Feranchak AP, Yun CH, Sutherland E, Simon F, Fitz JG, Doctor RB. 2001. Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia. Hepatology 33(1):166-176.
13. Gong Y, Deng S, Zhang M, Wang G, Minuk GY, Burczynski F. 2002. A cyclin-dependent kinase inhibitor (p21(WAF1/CIP1)) affects thymidine incorporation in human liver cancer cells. Br J Cancer 86(4):625-629.
14. Hultcrantz R, Mengarelli S, Strandvik B. 1986. Morphological findings in the liver of children with cystic fibrosis: A light and electron microscopical study. Hepatology 6(5):881-889.
15. Kuver R, Ramesh N, Lau S, Savard C, Lee SP, Osborne WR. 1994. Constitutive mucin secretion linked to CFTR expression. Biochem Biophys Res Commun 203(3):1457-1462.
16. Lindblad A, Hultcrantz R, Strandvik B. 1992. Bile-duct destruction and collagen deposition: A prominent ultrastructural feature of the liver in cystic fibrosis. Hepatology 16(2):372-381.
17. Lindblad A, Glaumann H, Strandvik B. 1998. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Hepatology 27(1):166-174.
18. Linsdell P, Hanrahan JW. 1998. Glutathione permeability of CFTR. Am J Physiol 275(1 Pt 1):C323-326.
19. Nathanson MH, Boyer JL. 1991. Mechanisms and regulation of bile secretion. Hepatology 14(3):551-566.
20. Noone PG, Pue CA, Zhou Z, Friedman KJ, Wakeling EL, Ganeshananthan M, Simon RH, Silverman LM, Knowles MR. 2000. Lung disease associated with the IVS8 5T allele of the CFTR gene. Am J Respir Crit Care Med 162(5):1919-1924.
21. Oppenheimer EH, Esterly JR. 1975a. Hepatic changes in young infants with cystic fibrosis: Possible relation to focal biliary cirrhosis. J Pediatr 86(5):683-689.
22. Oppenheimer EH, Esterly JR. 1975b. Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases. Perspect Pediatr Pathol 2:241-278.
23. Pilewski JM, Frizzell RA. 1999. Role of CFTR in airway disease. Physiol Rev 79(1 Suppl):S215-255.
24. Reisin IL, Prat AG, Abraham EH, Amara JF, Gregory RJ, Ausiello DA, Cantiello HF. 1994. The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. J Biol Chem 269(32):20584-20591.
25. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al. 1989. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245(4922): 1066-1073.
26. Rodriguez-Garay EA. 2003. Cholestasis: Human disease and experimental animal models. Ann Hepatol 2(4):150-158.
27. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, et al. 1989. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245(4922):1059-1065.
28. Schreiber R, Pavenstadt H, Greger R, Kunzelmann K. 2000. Aquaporin 3 cloned from Xenopus laevis is regulated by the cystic fibrosis transmembrane conductance regulator. FEBS Lett 475(3):291-295.
29. Shen H, Huang G, Hadi M, Choy P, Zhang M, Minuk GY, Chen Y, Gong Y. 2003. Transforming growth factor-betal downregulation of Smad1 gene expression in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 285(3):G539-546.
30. Sheth S, Shea JC, Bishop MD, Chopra S, Regan MM, Malmberg E, Walker C, Ricci R, Tsui LC, Durie PR, Zielenski J, Freedman SD. 2003. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet 113(3):286-292.
31. Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, Stutts MJ, Milgram SL. 1998. An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem 273(31):19797-19801.
32. Tanner MS, Taylor CJ. 1995. Liver disease in cystic fibrosis. Arch Dis Child 72(4):281-284.
33. Welsh MJ, Smith AE. 1993. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73(7):1251-1254.